For some, this cost might be a barrier
Figure from van der Aart-van der Beek AB, Nat Rev Nephrol, 2020 The Study Methods This was an international, event-driven, double-blind, parallel-group, randomized, placebo-controlled trial conducted at 387 sites in 28 countries comparing semaglutide to placebo in patients with T2DM and CKD, both being treated with baseline standard of care
For many patients, measurable weight loss, increased comfort and confidence in clothing and lifestyle choices, and better mobility after having gained energy typically happen after their first three months on semaglutide
The TLCO method has primarily been evaluated in renal blood oxygen level-dependent MRI with low intra- and interobserver variability, as reported elsewhere [34, 35]
Concurrent medications should be considered, particularly for patients taking multiple injectable medications
Losing extra weight can help control blood sugar levels, boost energy levels, and improve overall health and well-being